Histologic improvement following treatment with once weekly pegylated interferon alfa-2a (pegasysTM) and thrice weekly interferon alfa-2a (roferonTM) in patients with chronic hepatitis C and compensated cirrhosis
- 30 April 2000
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 118 (4) , A961
- https://doi.org/10.1016/s0016-5085(00)85987-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: